Skip to main content

Inovio Pharmaceuticals, Inc.

INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001055726

No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Inovio Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
183
−1 vs. Q2 2022
Shares held
116.0M
+2.58M (+2.3%) vs. Q2 2022
Total value
$200.0M
+$3.86M (+2.0%) vs. Q2 2022
New holders
24
58 more added
Sold out
25
41 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 183 institutions
Q1 2021: 219 institutionsQ2 2021: 211 institutionsQ3 2021: 213 institutionsQ4 2021: 209 institutionsQ1 2022: 201 institutionsQ2 2022: 185 institutionsQ3 2022: 183 institutionsQ4 2022: 186 institutionsQ1 2023: 177 institutionsQ2 2023: 135 institutionsQ3 2023: 127 institutionsQ4 2023: 116 institutionsQ1 2024: 89 institutionsQ2 2024: 96 institutionsQ3 2024: 98 institutionsQ4 2024: 105 institutionsQ1 2025: 108 institutionsQ2 2025: 103 institutionsQ3 2025: 99 institutionsQ4 2025: 101 institutionsQ1 2026: 99 institutionsQ2 2026: 101 institutions
Value heldQ3 2022: $200.0M
Q1 2021: $693.7MQ2 2021: $683.1MQ3 2021: $554.9MQ4 2021: $428.9MQ1 2022: $330.4MQ2 2022: $196.2MQ3 2022: $200.0MQ4 2022: $198.5MQ1 2023: $99.8MQ2 2023: $32.1MQ3 2023: $21.6MQ4 2023: $25.7MQ1 2024: $56.4MQ2 2024: $65.1MQ3 2024: $49.5MQ4 2024: $24.4MQ1 2025: $22.2MQ2 2025: $20.7MQ3 2025: $48.4MQ4 2025: $57.5MQ1 2026: $54.6MQ2 2026: $36.1M
Institutions holding INO and their total value by quarter
QuarterHoldersValue
Q2 2026101$36.1M
Q1 202699$54.6M
Q4 2025101$57.5M
Q3 202599$48.4M
Q2 2025103$20.7M
Q1 2025108$22.2M
Q4 2024105$24.4M
Q3 202498$49.5M
Q2 202496$65.1M
Q1 202489$56.4M
Q4 2023116$25.7M
Q3 2023127$21.6M
Q2 2023135$32.1M
Q1 2023177$99.8M
Q4 2022186$198.5M
Q3 2022183$200.0M
Q2 2022185$196.2M
Q1 2022201$330.4M
Q4 2021209$428.9M
Q3 2021213$554.9M
Q2 2021211$683.1M
Q1 2021219$693.7M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Inovio Pharmaceuticals, Inc.; share changes are against Q2 2022.

Institutions holding INO in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Charter Oak Capital Management, LLC0$00.00%−625−100.0%Sold out
Huntington National Bank0$00.00%−400−100.0%Sold out
MCF Advisors LLC0$00.00%−100−100.0%Sold out
Ellevest, Inc.0$00.00%−72−100.0%Sold out
Patriot Financial Group Insurance Agency, LLC0$00.00%−73−100.0%Sold out
MBM Wealth Consultants, LLC0$00.00%−30−100.0%Sold out
Global Wealth Management Investment Advisory, Inc.0$00.00%−250−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−200−100.0%Sold out
Urban Wealth Management, LLC––––Not filed